NCT07420491: The Efficacy and Safety of Reconyl in Acute Cough Treatment

Summary

This is a 2-arm, prospective, randomized, double-blind, parallel, controlled, non-inferiority study comparing Reconyl at a dose of 225 mg three times daily and Reconyl Placebo three times daily for a 7-day course of therapy. Reconyl is a combination of four Indonesian herbals, Vitex trifolia folium, Zingiber officinale rhizome, Abrus precatorius folium, and Phaleria macrocarpa fructus, which have been traditionally used in treating cough and common cold. A combination of these herbals is expected to relieve cough and soothe throat, provide a promising cough treatment which has no side effects.

Timeline

Start: 2025-06-26
Primary completion: 2025-10-03
Completion: 2025-10-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Reconyl	Traditional medicine (herbal / TCM)	225 mg	—

Indications

No indication recorded.